FdaApplication
ANDA 063221
Identifiers
- fda_app_no: ANDA063221
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | ANDA |
| approval_date | 1993-04-29 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | CEFTAZIDIME SODIUM | EQ 10MG BASE/ML | INJECTABLE;INJECTION |
| CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | CEFTAZIDIME SODIUM | EQ 40MG BASE/ML | INJECTABLE;INJECTION |
| CEFTAZIDIME SODIUM IN PLASTIC CONTAINER | CEFTAZIDIME SODIUM | EQ 20MG BASE/ML | INJECTABLE;INJECTION |
3 products